ASCE IRLV Exosome Solution
Advanced exosome-based formulation for intimate area rejuvenation. Utilizing ExoSCRT™ technology, ASCE IRLV delivers over 2.5× higher exosome purity compared to conventional methods, supporting tissue repair, hydration, and elasticity with clinically validated results.
ExoSCRT™ Technology & High-Purity Exosomes
ASCE IRLV employs proprietary ExoSCRT™ technology for the isolation and purification of exosomes, ensuring a high concentration of bioactive vesicles with minimal contaminants. Each vial contains exosomes enriched with growth factors and regenerative molecules, supporting optimal tissue renewal and anti-inflammatory effects. Laboratory analysis confirms exosome purity exceeding 95%, with particle size distribution under 200nm for enhanced tissue penetration.
Clinically Proven Benefits
Enhanced Lubrication
Improves vaginal moisture by 78% within 4 weeks (n=60, double-blind study)
Tissue Elasticity
Increases tissue elasticity by 62% and reduces laxity scores
Reduced Discomfort
Decreases discomfort during intercourse by 54% (patient-reported outcomes)
Aesthetic Improvement
Improves skin texture and color uniformity of the intimate area
Product Specifications
- Active Ingredient: Exosomes (20mg/vial)
- Formulation: 20mg lyophilized powder + 2.5ml solvent (2 vials per box, for mixing)
- Technology: ExoSCRT™ proprietary exosome isolation
- Purity: >95% exosome content, particle size <200nm
- Packaging: 1 box = 1 lyophilized vial + 1 solvent vial
- Storage: 2-8°C, protect from light
- Shelf Life: 24 months from manufacture date
Professional Use Protocol
- Preparation: Mix 20mg lyophilized powder with 2.5ml solvent immediately before use
- Administration: Apply via vaginal applicator or microinjection by trained medical personnel
- Recommended Course: 1 session every 2-4 weeks, total 3-4 sessions
- Post-Procedure: Advise patients to avoid intercourse for 48 hours post-application
- Device Compatibility: Suitable for use with standard vaginal applicators
Therapeutic Applications
Vaginal Dryness
Apply 2.5ml reconstituted solution via applicator. Clinical data shows 78% improvement in lubrication and comfort after 3 sessions.
Tissue Laxity
Microinjection protocol: 0.5ml per site, 4-6 sites per session. Notable improvement in elasticity and firmness within 8 weeks.
Aesthetic Rejuvenation
For skin texture and color: topical application or microinjection, 1 session every 3 weeks. 65% improvement in patient satisfaction scores.
Important Clinical Disclaimer
Notice:
Clinical outcomes may vary depending on individual patient factors. All procedures must be performed by licensed healthcare professionals. Contraindications include active infections, pregnancy, and known hypersensitivity to exosome products.
Effectiveness may differ for each individual. This product is not intended to diagnose, treat, cure, or prevent any disease. Regular follow-up and monitoring are recommended. Discontinue use immediately if adverse reactions occur.
Reviews
There are no reviews yet.